Financial Connections Group, Inc. Bristol Myers Squibb CO Transaction History

Financial Connections Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $96,960 - $115,700	2,000 New	2,000 $102,000
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $180,299 - $200,194	2,830 New	2,830 $180,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $5,809 - $6,398	-80 Reduced 8.18%	898 $69,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $22,932 - $27,497	-373 Reduced 27.61%	978 $71,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $72,454 - $84,464	1,351 New	1,351 $84,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Financial Connections Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Connections Group, Inc. with notifications on news.